Hypertension prevalence and the status of awareness, treatment, and control in the United States. Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee
- PMID: 3997227
- DOI: 10.1161/01.hyp.7.3_pt_1.457
Hypertension prevalence and the status of awareness, treatment, and control in the United States. Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee
Abstract
Estimates of the prevalence of hypertension in the United States have varied owing to differences in interpretation and extrapolation of the data. In 1978 the National High Blood Pressure Education Program issued a consensus document estimating the prevalence of high blood pressure in the United States. Results from the 1976-1980 National Health and Nutrition Examination Survey (NHANES II) allow for a revised estimate. The purpose of this report was to arrive at consensus on a prevalence figure and also to provide information on the distribution of hypertension by blood pressure level, age, race, and sex. The prevalence estimates used are based on hypertension defined as blood pressure measurements greater than or equal to 140/90 mm Hg (average of 3 readings taken on 1 occasion) or self-reported taking of antihypertensive medication. Based on NHANES II data, blacks have a higher prevalence than whites (38% vs 29%) and men show a higher prevalence than women (33% vs 27%). These data again confirm the tendency for the prevalence of hypertension to increase with age in the U.S. population--this holds true for blacks, whites, men, and women. Progress in high blood pressure control efforts has traditionally been measured by changes in the status of awareness, treatment, and control. Changing the hypertension threshold from 160/95 to 140/90 mm Hg, as recently recommended, substantially lowers these measures: the percentage of hypertensives aware of their condition falls from 74% to 54%, the percentage taking antihypertensive medication falls from 56% to 33%, and the percentage with controlled hypertension decreases from 34% to 11%. These apparent decreases reflect a change in the frame of reference rather than changes in hypertension treatment status. In addition, hypertension prevalence rates from NHANES II (1976-1980) were applied to 1983 Bureau of the Census population figures to estimate the total number of Americans with hypertension and their distribution by age, sex, race, and severity of blood pressure level. Since NHANES II did not include persons 75 years of age or older in its sample, data from a pilot study on systolic hypertension in the elderly were used for prevalence estimates in this age group. Estimates for children under 6 years of age and hypertensive persons controlling their pressures without medication could not be included in this analysis because of a lack of reliable data on these groups.
Similar articles
-
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.JAMA. 2003 Jul 9;290(2):199-206. doi: 10.1001/jama.290.2.199. JAMA. 2003. PMID: 12851274
-
Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).Lancet. 2017 Dec 9;390(10112):2549-2558. doi: 10.1016/S0140-6736(17)32478-9. Epub 2017 Nov 5. Lancet. 2017. PMID: 29102084
-
Distribution of blood pressure and hypertension in Canada and the United States.Am J Hypertens. 2001 Nov;14(11 Pt 1):1099-105. doi: 10.1016/s0895-7061(01)02211-7. Am J Hypertens. 2001. PMID: 11724207
-
Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid?J Hum Hypertens. 1997 Apr;11(4):213-20. doi: 10.1038/sj.jhh.1000426. J Hum Hypertens. 1997. PMID: 9185025 Review.
-
Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines.Hypertens Res. 2020 Dec;43(12):1344-1351. doi: 10.1038/s41440-020-0508-z. Epub 2020 Jul 7. Hypertens Res. 2020. PMID: 32636526 Review.
Cited by
-
Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):731-6. doi: 10.1007/s10096-003-1034-z. Epub 2003 Nov 11. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14610658
-
Race and hypertension. What is clinically relevant?Drugs. 1994 Jun;47(6):914-32. doi: 10.2165/00003495-199447060-00005. Drugs. 1994. PMID: 7521831 Review.
-
Evidence for an expanded hypertension care cascade in low- and middle-income countries: a scoping review.BMC Health Serv Res. 2022 Jun 27;22(1):827. doi: 10.1186/s12913-022-08190-0. BMC Health Serv Res. 2022. PMID: 35761254 Free PMC article.
-
The effect of medication compliance on the control of hypertension.J Gen Intern Med. 1987 Sep-Oct;2(5):298-305. doi: 10.1007/BF02596162. J Gen Intern Med. 1987. PMID: 3655955
-
Hypertension and cognitive function.J Clin Psychol Med Settings. 1995 Sep;2(3):233-48. doi: 10.1007/BF01990879. J Clin Psychol Med Settings. 1995. PMID: 24226195
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical